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contributions of neutral drift and the
impact of a few large-effect mutations
versus many small-effect ones will need
to be evaluated. Work on protein-protein
interactions should be extended to other
systems where cross-reaction is an issue,
such as in other TA modules documented
as cross-reacting (Zhu et al., 2010).
Cross-reaction is also pertinent in other
types of natural systems, as has been
shown in some SH3 systems (Zarrinpar
et al., 2003) and in the evolution of meta-
bolic pathways (Kim and Copley, 2012).
Ultimately, there are many other variables
likely to be relevant in natural evolutionthat will surely be more difficult to ascer-
tain in experimental systems. As with
this work by Aakre et al., development of
other new approaches may be essential
for dissecting additional features in the
evolution of protein-protein interactions.REFERENCES
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Bacterial type VI secretion is an offensive and defensive weapon that utilizes a molecular warhead
to inject toxins into neighboring cells. In this issue of Cell, Whitney et al. report a new class of toxin
that disrupts the coremetabolism of recipient cells and uncover a surprising requirement for EF-Tu.Nowhere is life more fiercely competitive
than in the invisible world of bacteria and
other microbes. Vast in numbers, these
diminutive creatures disable their com-
petitors by assailing each other with a
range of weapons that include dispers-
ible small molecules (antibiotics) and
protein toxins (e.g., colicins). Perhaps
the most cunning weapon is the type VI
secretion (T6S) system of Vibrio, Pseudo-
monas, and certain other Gram-negative
bacteria, which forms a miniscule spring-
loaded dagger—a phage-tail-like con-
tractile apparatus, complete with a
molecularly poisoned sharp tip—to
instantaneously inject protein toxins at
point-blank range into neighboring cells.
Evoking the infamous Umbrella Murder,
in which Bulgarian dissident Georgi Mar-
kov was assassinated by a ricin-laced
projectile fired from an umbrella, the
spear-gun-like T6S system fires into eu-
karyotic cells and bacteria alike, breach-
ing their membranes and delivering toxiceffector molecules with different modes
of action. In this issue of Cell, Whitney
et al. (2015) report that a recently discov-
ered effector poisons cells differently
from previously known effectors and,
surprisingly, requires the translation elon-
gation factor EF-Tu to intoxicate target
cells.
The first functionally characterized T6S
system, from V. cholerae, was revealed
by its role in warding off predation by
amoebae (Pukatzki et al., 2006), but T6S
systems are increasingly viewed as part
of an arsenal that bacteria use against
one another. Indeed, bacteria can even
be seen duking it out, repeatedly attack-
ing and counterattacking in a process
termed ‘‘dueling’’ (Basler et al., 2013).
Characterized T6S effector molecules
include lipases that target the bacterial
membrane, peptidoglycan hydrolases
that degrade the cell wall, and nucleases
that act on the nucleoid (Figure 1A) (Du-
rand et al., 2014). Structural and mecha-nistic studies of a recently discovered
effector, called Tse6, by Whitney et al.
(2015) reveal yet a different mechanism.
Tse6 resembles diphtheria toxin and
other toxins that transfer ADP-ribose
from NAD+ onto proteins to inactivate
them, but Tse6 is a pure glycohydrolase
that intoxicates cells by depleting them
of cytoplasmic nicotinamide adenine
dinucleotide (phosphate) (NAD(P)+).
Attacker cells expressing Tse6 are pro-
tected by its cognate immunity protein,
Tsi6, which tightly plugs the Tse6 active
site.
An enduring question is where in the
target cell the warhead of effector pro-
teins is initially delivered. Is it to the peri-
plasm only, to the cytoplasm, or to both?
In principle, the phage-tail-like tube of
the T6S apparatus is long enough to
penetrate 500 nm into a target cell
(Basler et al., 2012; Ho et al., 2014),
which could allow for direct delivery
into the cytoplasm. But lipases and, October 22, 2015 ª2015 Elsevier Inc. 537
Figure 1. T6S Effectors and Their Sites of Action
(A) The T6S apparatus delivers effectors to the periplasmic space of Gram-negative target bacteria. It is
unknown whether it can also breach the peptidoglycan and deliver effectors directly to the cytoplasm.
Some effectors, such as lipases and peptidoglycan hydrolases (amidases or glycosylases), act within the
periplasmic space. Others, such as nucleases and the newly discovered NAD(P)+ hydrolase Tse6, act in
the cytoplasm.
(B) Model for delivery and translocation of the Tse6 effector. When loaded on the T6S apparatus, the
hydrophobic transmembrane regions of Tse6 are protected by its chaperone, Eag6 (left). Either in transit or
once delivered, Eag6 dissociates from Tse6, exposing its three transmembrane regions. Tse6 then par-
titions into the cytoplasmic membrane, where its C-terminal effector domain is drawn into the cytoplasm
by association with cytoplasmic EF-Tu (center). After being pulled into the cytoplasm, the effector in-
toxicates the target cell via its NAD(P)+ hydrolase activity (right).peptidoglycan hydrolases only need to
reach the periplasmic space, and the
cell wall might present a barrier to me-
chanical puncture. On the other hand,
nuclease effectors and the Tse6
NAD(P)+ hydrolase require entry into the
cytoplasm to reach their targets. Until
an attacking cell is visualized during the
act of firing into its target, we will be
forced to make inferences about how
the toxins reach their targets. However,
a surprising requirement of Tse6 sheds
light on the mechanism of effector deliv-
ery for at least one toxin.
While investigating the interaction of
Tse6 with other cellular proteins, the au-538 Cell 163, October 22, 2015 ª2015 Elsevithors discovered that the NAD(P)+ hydro-
lase forms a complex with the translation
elongation factor EF-Tu. The interaction
is strong and specific, and substitution
of a single amino acid, identified in a
Tse6-EF-Tu co-crystal structure, abol-
ished Tse6 binding to EF-Tu. Remarkably,
when this mutant Tse6 was introduced
into attacker cells, they could no longer
disable target cells, suggesting a specific
requirement for EF-Tu in the delivery or
activity of the toxin.
How are we to understand the unex-
pected requirement for EF-Tu in Tse6
toxicity? By using the non-interacting
mutant, the authors ruled out several pos-er Inc.sibilities. Interaction with EF-Tu is
required neither for the stability of the
Tse6 protein nor for its NAD(P)+ hydrolase
activity. They also showed that it is not
required for export of Tse6 from attacker
cells. Thus, by a process of elimination,
the authors conclude that the binding of
Tse6 to EF-Tu facilitates the entry of
Tse6 into the cytoplasm of target cells.
In their model, Tse6 is delivered by the
T6S system into the periplasm of a target
cell along with its chaperone (Eag6),
which shields its hydrophobic transmem-
brane regions. Tse6 then inserts into the
cytoplasmic membrane of the target cell
and is granted entry to the cytoplasm by
progressively interacting with EF-Tu as it
crosses the membrane (Figure 1B).
Thus, the T6S system does not deliver
the toxin into the cytoplasm. Rather,
Tse6 only needs to reach the cytoplasmic
membrane of the target cell, where it then
becomes trapped in the cytoplasm by
EF-Tu. If this model is correct, a comple-
mentary mutant of EF-Tu that is specif-
ically blocked in binding to Tse6 would
be expected to confer immunity to the
toxin in target cells.
The Tse6 results do not exclude the
possibility that other T6S effectors with
cytoplasmic targets are directly delivered
to the target cytoplasm, as Tse6 may
have evolved a special, EF-Tu-depen-
dent mode of cytoplasmic entry that is
not shared by other cytoplasmic effec-
tors. Perhaps other effectors, such
as the T6S-delivered nuclease of
P. aeruginosa (Hachani et al., 2014), are
injected directly into the cytoplasm
without the aid of target cell proteins.
Finally, we note that T6S systems are
not restricted to the delivery of toxins,
as in the fascinating case of the transfer
of proteins that mediate self/non-self
identity between cells of Proteus mirabilis
(Wenren et al., 2013).REFERENCES
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The current obesity epidemic has focused a great deal of attention on mechanisms controlling
energy balance. While diet and nutrient absorption affect energy intake, on the other side of the
equation, energy expenditure is determined by basal metabolism, physical activity, and adaptive
thermogenesis. Given various challenges inmodulating these energy balancemechanisms to com-
bat human obesity, many efforts have concentrated on how it might be possible to achieve weight
loss through increased thermogenesis. In this issue of Cell, Kazak et al. describe a previously un-
recognized molecular pathway for thermogenesis in fat cells.Non-shivering thermogenesis occurs pri-
marily in brown adipose tissue in rodents,
but also has been detected in so called
‘‘beige’’ adipocytes, thought to reside
mainly in subcutaneous fat tissue inter-
spersed with classic white adipocytes
(Wu et al., 2012; Young et al., 1984).
Much of human thermogenic fat most
closely resembles the rodent beige adi-
pose tissue (Shinoda et al., 2015). Beige
and brown adipocytes both express un-
coupling protein 1 (Ucp1), which resides
on the inner mitochondrial membrane.
While the electron transport chain drives
protons into the intermembrane space in
mitochondria, creating a proton gradient
across the inner membrane to drive the
synthesis of ATP (Figure 1A), Ucp1 cre-
ates a pore through which protons
disperse into the mitochondrial matrix,
thereby generating heat and uncoupling
ATP synthesis (Figure 1B). Cold exposure
or increased sympathetic activity stimu-
lated by feeding activates thermogenesis
through adrenergic activation of Ucp1
expression (Ricquier et al., 1986; Scar-
pace et al., 1997).
Although Ucp1 is well established as an
important component of thermogenesis,
investigators have long known that thetranscriptional regulation of Ucp1 cannot
fully explain thermic responses. For
example, the thermic effect of feeding is
far too rapid to be explained by a tran-
scriptional effect alone (Scarpace et al.,
1997). Furthermore, Ucp1 knockout
mice can adapt to chronic cold exposure
when the temperature transition is
gradual (Golozoubova et al., 2001). Non-
shivering thermogenesis has also been
characterized in muscle, where Sarcolipin
(Sln) uncouples ATP hydrolysis from Ca2+
transport, thereby creating a futile cycle
that generates heat (Bal et al., 2012).
However, Ucp1/Sln double-knockout
mice still retain the ability to maintain ther-
mal regulation when slowly adapted to the
cold (Rowland et al., 2015), leaving a gap
in our understanding of how thermogene-
sis occurs.
To fill in this gap, Bruce Spiegelman and
his colleagues, including mass spec
expert StevenGygi, conducted proteomic
and genomic studies comparing beige,
white, and brown adipocytes (Kazak
et al., 2015). KEGG pathway analysis of
proteins preferentially expressed in beige
versus brown fat revealed several compo-
nents of the arginine/creatine and proline
metabolism pathways. These findingswere confirmed when the analysis was
limited to proteins specifically enriched
in purified mitochondrial fractions. Pro-
teins that promote both creatine synthesis
and phosphorylation, including the mito-
chondrial creatine kinase CMKT2 and
the majority of ATP synthase subunits,
were elevated in mitochondria from beige
fat. Creatine kinase (CK) activity was also
specifically induced in beige fat mito-
chondria derived from mice exposed to
cold, suggesting that it is somehow under
adrenergic control. Together, these find-
ings hinted that a futile creatine phos-
phorylation and dephosphorylation cycle
might somehow be involved in generating
heat specifically in mitochondria from
beige adipocytes.
CK catalyzes the phosphorylation of
creatine using ATP, generating phospho-
creatine and ADP. In tissues with high
ATP demands, such as skeletal muscle,
the high-energy phosphate bound to cre-
atine can be transferred to ADP to
generate cytosolic ATP (Wyss and Kad-
durah-Daouk, 2000). If creatine were
serving to regenerate mitochondrial ATP
through classical CK-mediated phospho-
transferase activity, it would be expected
to boost respiration as a molar equivalent, October 22, 2015 ª2015 Elsevier Inc. 539
